Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Miller, Brandon A ^a   Turan, Nefize ^a   Chau, Monica ^a   Pradilla, Gustavo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CILOSTAZOL; CLAZOSENTAN; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; AUTACOID; BIOLOGICAL MARKER;

ANIMAL MODEL; BRAIN ARTERY ANEURYSM; BRAIN INJURY; BRAIN VASOSPASM; ENCEPHALITIS; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; MULTICENTER STUDY (TOPIC); NEUROLOGIC DISEASE; NEUROLOGICAL DETERIORATION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBARACHNOID HEMORRHAGE; BRAIN INJURIES; COMPLICATION; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASOSPASM, INTRACRANIAL;

BIOLOGICAL MARKERS; BRAIN INJURIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84904807466     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/384342     Document Type: Review

References (236)

1. Kaynar M. Y., Tanriverdi T., Kafadar A. M., Kacira T., Uzun H., Aydin S., Gumustas K., Dirican A., Kuday C., Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2004 101 6 1030 1036 2-s2.0-16544384377 10.3171/jns.2004.101.6.1030 (Pubitemid 43186457)
2. Kikuchi T., Okuda Y., Kaito N., Abe T., Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurological Research 1995 17 2 106 108 2-s2.0-0028963732
3. Polin R. S., Bavbek M., Shaffrey M. E., Billups K., Bogaev C. A., Kassell N. F., Lee K. S., Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. Journal of Neurosurgery 1998 89 4 559 567 2-s2.0-0031691441 (Pubitemid 28440924)
4. Danton G. H., Dietrich W. D., Inflammatory mechanisms after ischemia and stroke. Journal of Neuropathology and Experimental Neurology 2003 62 2 127 136 2-s2.0-0037312886 (Pubitemid 36176947)
5. Zhang R. L., Zhang Z. G., Chopp M., Zivin J. A., Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. Stroke 1999 30 3 624 629 2-s2.0-0001373003 (Pubitemid 29115402)
6. Frijns C. J. M., Kappell L. J., Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002 33 8 2115 2122 2-s2.0-0036326170 10.1161/01.STR.0000021902.33129.69 (Pubitemid 34840079)
7. Schneider U. C., Schiffler J., Hakiy N., Horn P., Vajkoczy P., Functional analysis of Pro-inflammatory properties within the cerebrospinal fluid after subarachnoid hemorrhage in vivo and in vitro. Journal of Neuroinflammation 2012 9, article 28 2-s2.0-84856611258 10.1186/1742-2094-9-28
8. Tanriverdi T., Sanus G. Z., Ulu M. O., Tureci E., Uzun H., Aydin S., Kaynar M. Y., Serum and cerebrospinal fluid concentrations of E-selectin in patients with aneurysmal subarachnoid hemorrhage. Brazilian Journal of Medical and Biological Research 2005 38 11 1703 1710 2-s2.0-27944482971 (Pubitemid 41671759)
9. Gaetani P., Tartara F., Pignatti P., Tancioni F., Rodriguez Y Baena R., de Benedetti F., Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurological Research 1998 20 4 337 342 2-s2.0-0031806362 (Pubitemid 28247128)
10. Xie X., Wu X., Cui J., Li H., Yan X., Increase ICAM-1 and LFA-1 expression by cerebrospinal fluid of subarachnoid hemorrhage patients: involvement of TNF- α Brain Research 2013 1512 89 96 2-s2.0-84879843935 10.1016/j.brainres.2013.03.041
11. Fassbender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schütt S., Fritzinger M., Horn P., Vajkoczy P., Kreisel S., Brunner J., Schmiedek P., Hennerici M., Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. Journal of Neurology Neurosurgery and Psychiatry 2001 70 4 534 537 2-s2.0-0035056594 10.1136/jnnp.70.4.534 (Pubitemid 32269696)
12. Hopkins S. J., McMahon C. J., Singh N., Galea J., Hoadley M., Scarth S., Patel H., Vail A., Hulme S., Rothwell N. J., King A. T., Tyrrell P. J., Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection. Journal of Neuroinflammation 2012 9, article 255 2-s2.0-84869864057 10.1186/1742-2094-9-255
13. Fabender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schütt S., Fritzinger M., Horn P., Vajkoczy P., Wendel-Wellner M., Ragoschke A., Kuehl S., Brunner J., Schürer L., Schmiedeck P., Hennerici M., Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000 31 12 2971 2975 2-s2.0-0033661938
14. Masaoka H., Suzuki R., Hirata Y., Emori T., Marumo F., Hirakawa K., Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. The Lancet 1989 2 8676 1402 2-s2.0-0024307026 (Pubitemid 20003021)
15. Ehrenreich H., Lange M., Near K. A., Anneser F., Schoeller L. A. C., Schmid R., Winkler P. A., Kehrl J. H., Schmiedek P., Goebel F.-D., Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Research in Experimental Medicine 1992 192 1 257 268 2-s2.0-0026722757 10.1007/BF02576282
16. Hamann G., Isenberg E., Strittmatter M., Schimrigk K., Absence of elevation of big endothelin in subarachnoid hemorrhage. Stroke 1993 24 3 383 386 2-s2.0-0027465511 (Pubitemid 23070044)
17. Sozen T., Tsuchiyama R., Hasegawa Y., Suzuki H., Jadhav V., Nishizawa S., Zhang J. H., Immunological response in early brain injury after SAH. Acta Neurochirurgica, Supplementum 2011 110, part 1 57 61 2-s2.0-79952278614 10.1007/978-3-7091-0353-1-10
18. Claassen J., Carhuapoma J. R., Kreiter K. T., Du E. Y., Connolly E. S., Mayer S. A., Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002 33 5 1225 1232 2-s2.0-0036094267 10.1161/01.STR.0000015624.29071.1F (Pubitemid 34520392)
19. Horstmann S., Su Y., Koziol J., Meyding-Lamadé U., Nagel S., Wagner S., MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. Journal of the Neurological Sciences 2006 251 1-2 82 86 2-s2.0-33751249568 10.1016/j.jns.2006.09.005 (Pubitemid 44792144)
20. Mocco J., Mack W. J., Kim G. H., Lozier A. P., Laufer I., Kreiter K. T., Sciacca R. R., Solomon R. A., Mayer S. A., Connolly E. S. Jr., Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2002 97 3 537 541 2-s2.0-0036711931 (Pubitemid 34994369)
21. Kim G. H., Kellner C. P., Hahn D. K., Desantis B. M., Musabbir M., Starke R. M., Rynkowski M., Komotar R. J., Otten M. L., Sciacca R., Schmidt J. M., Mayer S. A., Connolly E. S. Jr., Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2008 109 1 38 43 2-s2.0-48049086124 10.3171/JNS/2008/109/7/0038
22. Mack W. J., Mocco J., Hoh D. J., Huang J., Choudhri T. F., Kreiter K. T., Lozier A., Opperman M., Poisik A., Yorgason J., Solomon R. A., Mayer S. A., Connolly E. S. Jr., Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2002 96 1 71 75 2-s2.0-0036123191 (Pubitemid 34229988)
23. Nissen J. J., Mantle D., Blackburn A., Barnes J., Wooldridge T., Gregson B., Mendelow A. D., The selectin superfamily: the role of selectin adhesion molecules in delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica, Supplement 2000 76 55 60 2-s2.0-0034574406
24. Kubo Y., Ogasawara K., Kakino S., Kashimura H., Tomitsuka N., Sugawara A., Ogawa A., Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage. Surgical Neurology 2008 69 6 592 596 2-s2.0-43449101537 10.1016/j.surneu.2008.02.014 (Pubitemid 351671852)
25. Dhar R., Diringer M. N., The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocritical Care 2008 8 3 404 412 2-s2.0-51449095256 10.1007/s12028-008-9054-2
26. Tam A. K. H., Ilodigwe D., Mocco J., Mayer S., Kassell N., Ruefenacht D., Schmiedek P., Weidauer S., Pasqualin A., MacDonald R. L., Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Neurocritical Care 2010 13 2 182 189 2-s2.0-77957937025 10.1007/s12028-010-9402- x
27. Muroi C., Hugelshofer M., Seule M., Tastan I., Fujioka M., Mishima K., Keller E., Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2013 72 3 367 375 2-s2.0-84874381633 10.1227/NEU.0b013e31828048ce
28. de Pablo R., Monserrat J., Reyes E., Díaz D., Rodríguez- Zapata M., De La Hera A., Prieto A., Álvarez-Mon M., Circulating sICAM-1 and sE-Selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome. European Journal of Internal Medicine 2013 24 2 132 138 2-s2.0-84873734800 10.1016/j.ejim.2012.10.009
29. Takizawa T., Tada T., Kitazawa K., Tanaka Y., Hongo K., Kameko M., Uemura K.-I., Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurological Research 2001 23 7 724 730 2-s2.0-0034790802 10.1179/016164101101199243 (Pubitemid 32952702)
30. Mathiesen T., Andersson B., Loftenius A., von Holst H., Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. Journal of Neurosurgery 1993 78 4 562 567 2-s2.0-0027469626 (Pubitemid 23099464)
31. Aoki T., Nishimura M., Targeting chronic inflammation in cerebral aneurysms: focusing on NF- B as a putative target of medical therapy. Expert Opinion on Therapeutic Targets 2010 14 3 265 273 2-s2.0-77149127689 10.1517/14728221003586836
32. Aoki T., Kataoka H., Ishibashi R., Nozaki K., Egashira K., Hashimoto N., Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 2009 40 3 942 951 2-s2.0-62449098668 10.1161/STROKEAHA.108. 532556
33. Hasan D., Hashimoto T., Kung D., Loch MacDonald R., Richard Winn H., Heistad D., Upregulation of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E2 synthase-1 (mPGES-1) in wall of ruptured human cerebral aneurysms: preliminary results. Stroke 2012 43 7 1964 1967 2-s2.0-84863300595 10.1161/STROKEAHA.112.655829
34. Hasan D. M., Chalouhi N., Jabbour P., Magnotta V. A., Kung D. K., Young W. L., Imaging aspirin effect on macrophages in the wall of human cerebral aneurysms using ferumoxytol-enhanced MRI: preliminary results. Journal of Neuroradiology 2013 40 3 187 191 2-s2.0-84880045172 10.1016/j.neurad.2012.09.002
35. Hasan D. M., Mahaney K. B., Brown R. D., Meissner I., Piepgras D. G., Huston J., Capuano A. W., Torner J. C., Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011 42 11 3156 3162 2-s2.0-80054988307 10.1161/STROKEAHA.111.619411
36. Jia W., Wang R., Zhao J., Liu I., Zhang D., Wang X., Han X., E-selectin expression increased in human ruptured cerebral aneurysm tissues. Canadian Journal of Neurological Sciences 2011 38 6 858 862 2-s2.0-80155151819
37. Chalouhi N., Ali M. S., Starke R. M., Jabbour P. M., Tjoumakaris S. I., Gonzalez L. F., Rosenwasser R. H., Koch W. J., Dumont A. S., Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators of Inflammation 2012 2012 12 2-s2.0-84872124680 10.1155/2012/271582 271582
38. Chalouhi N., Hoh B. L., Hasan D., Review of cerebral aneurysm formation, growth, and rupture. Stroke 2013 44 12 3613 3622
39. Marbacher S., Fandino J., Kitchen N. D., Standard intracranial in vivo animal models of delayed cerebral vasospasm. British Journal of Neurosurgery 2010 24 4 415 434 2-s2.0-77955774940 10.3109/02688691003746274
40. McGirt M. J., Pradilla G., Legnani F. G., Thai Q.-A., Recinos P. F., Tamargo R. J., Clatterbuck R. E., Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 2006 58 5 945 951 2-s2.0-33646836591 10.1227/01.NEU.0000210262. 67628.7E
41. Han B. H., Vellimana A. K., Zhou M.-L., Milner E., Zipfel G. J., Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage. Neurosurgery 2012 70 1 178 187 2-s2.0-84856108864 10.1227/NEU.0b013e31822ec2b0
42. Altay O., Hasegawa Y., Sherchan P., Suzuki H., Khatibi N. H., Tang J., Zhang J. H., Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice. Critical Care Medicine 2012 40 6 1908 1913 2-s2.0-84861527226 10.1097/CCM.0b013e3182474bc1
43. Prunell G. F., Svendgaard N.-A., Alkass K., Mathiesen T., Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 2005 56 5 1082 1091 2-s2.0-18244372692 10.1227/01.NEU.0000157966.76590.39 (Pubitemid 40628120)
44. Kooijman E., Nijboer C. H., van Velthoven C. T., Kavelaars A., Kesecioglu J., Heijnen C. J., The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies. Journal of Neuroinflammation 2014 11 1 2
45. Marc Simard J., Geng Z., Kyoon Woo S., Ivanova S., Tosun C., Melnichenko L., Gerzanich V., Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2009 29 2 317 330 2-s2.0-59149087488 10.1038/jcbfm.2008.120
46. Handa Y., Kubota T., Kaneko M., Tsuchida A., Kobayashi H., Kawano H., Kubota T., Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochirurgica 1995 132 1-3 92 97 2-s2.0-0028888696 10.1007/BF01404854
47. Aihara Y., Kasuya H., Onda H., Hori T., Takeda J., Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 2001 32 1 212 217 2-s2.0-0035155769 (Pubitemid 32063848)
48. Zhou M.-L., Wu W., Ding Y.-S., Zhang F.-F., Hang C.-H., Wang H.-D., Cheng H.-L., Yin H.-X., Shi J.-X., Expression of Toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Research 2007 1173 1 110 116 2-s2.0-34548853436 10.1016/j.brainres.2007.07.059 (Pubitemid 47445451)
49. Ma C.-X., Yin W.-N., Cai B.-W., Wu J., Wang J.-Y., He M., Sun H., Ding J.-L., You C., Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chinese Medical Journal 2009 122 13 1575 1581 2-s2.0-70349546129 10.3760/cma.j.issn.0366-6999.2009.13.019
50. Altay O., Suzuki H., Hasegawa Y., Ostrowski R. P., Tang J., Zhang J. H., Isoflurane on brain inflammation. Neurobiology of Disease 2013 62 365 371
51. Altay O., Suzuki H., Hasegawa Y., Caner B., Krafft P. R., Fujii M., Tang J., Zhang J. H., Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. Stroke 2012 43 9 2513 2516 2-s2.0-84865584830 10.1161/STROKEAHA.112.661728
52. Jiang Y., Liu D.-W., Han X.-Y., Dong Y.-N., Gao J., Du B., Meng L., Shi J.-G., Neuroprotective effects of anti-tumor necrosis factor-alpha antibody on apoptosis following subarachnoid hemorrhage in a rat model. Journal of Clinical Neuroscience 2012 19 6 866 872 2-s2.0-84861182070 10.1016/j.jocn.2011.08.038
53. O'Connor J. J., Targeting tumour necrosis factor- α in hypoxia and synaptic signalling. Irish Journal of Medical Science 2013 182 2 157 162 2-s2.0-84878353280 10.1007/s11845-013-0911-4
54. Friedrich V., Flores R., Sehba F. A., Cell death starts early after subarachnoid hemorrhage. Neuroscience Letters 2012 512 1 6 11 2-s2.0-84858002449 10.1016/j.neulet.2012.01.036
55. Tariq A., Ai J., Chen G., Sabri M., Jeon H., Shang X., Macdonald R. L., Loss of long-term potentiation in the hippocampus after experimental subarachnoid hemorrhage in rats. Neuroscience 2010 165 2 418 426 2-s2.0-71549118818 10.1016/j.neuroscience.2009.10.040
56. Jeon H., Ai J., Sabri M., Tariq A., Macdonald R. L., Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience 2010 169 4 1805 1814 2-s2.0-77955430665 10.1016/j.neuroscience.2010.06.039
57. Han S. M., Wan H., Kudo G., Foltz W. D., Vines D. C., Green D. E., Zoerle T., Tariq A., Brathwaite S., D'Abbondanza J., Ai J., Macdonald R. L., Molecular alterations in the hippocampus after experimental subarachnoid hemorrhage. Journal of Cerebral Blood Flow & Metabolism 2013 34 1 108 117
58. Tong L., Aleph Prieto G., Kramár E. A., Smith E. D., Cribbs D. H., Lynch G., Cotman C. W., Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1 β via p38 mitogen-activated protein kinase. Journal of Neuroscience 2012 32 49 17714 17724 2-s2.0-84870524516 10.1523/JNEUROSCI.1253-12.2012
59. Simard J. M., Tosun C., Ivanova S., Kurland D. B., Hong C., Radecki L., Gisriel C., Mehta R., Schreibman D., Gerzanich V., Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage. Translational Stroke Research 2012 3 supplement 1 155 165 2-s2.0-84862248353 10.1007/s12975-012-0166-9
60. Cobelens P. M., Tiebosch I. A. C. W., Dijkhuizen R. M., van der Meide P. H., Zwartbol R., Heijnen C. J., Kesecioglu J., van den Bergh W. M., Interferon- β attenuates lung inflammation following experimental subarachnoid hemorrhage. Critical Care 2010 14 4, article R157 2-s2.0-77955816691 10.1186/cc9232
61. Wartenberg K. E., Mayer S. A., Medical complications after subarachnoid hemorrhage. Neurosurgery Clinics of North America 2010 21 2 325 338 2-s2.0-77951042482 10.1016/j.nec.2009.10.012
62. Lin C.-L., Dumont A. S., Calisaneller T., Kwan A.-L., Hwong S.-L., Lee K. S., Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surgical Neurology 2005 64 3 201 206 2-s2.0-23744502674 10.1016/j.surneu.2005.04.038 (Pubitemid 41140128)
63. Nakayama T., Illoh K., Ruetzler C., Auh S., Sokoloff L., Hallenbeck J., Intranasal administration of E-selectin to induce immunological tolerization can suppress subarachnoid hemorrhage-induced vasospasm implicating immune and inflammatory mechanisms in its genesis. Brain Research 2007 1132 1 177 184 2-s2.0-33846195508 10.1016/j.brainres.2006.09.116 (Pubitemid 46096439)
64. Clatterbuck R. E., Oshiro E. M., Hoffman P. A., Dietsch G. N., Pardoll D. M., Tamargo R. J., Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats. Journal of Neurosurgery 2002 97 3 676 682 2-s2.0-0036714417 (Pubitemid 34994386)
65. Pradilla G., Wang P. P., Legnani F. G., Ogata L., Dietsch G. N., Tamargo R. J., Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. Journal of Neurosurgery 2004 101 1 88 92 2-s2.0-3042615226 (Pubitemid 38808465)
66. Clatterbuck R. E., Gailloud P., Ogata L., Gebremariam A., Dietsch G. N., Murphy K. J., Tamargo R. J., Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. Journal of Neurosurgery 2003 99 2 376 382 2-s2.0-0042345024 (Pubitemid 36900133)
67. Jdrzejowska-Szypułka H., Larysz-Brysz M., Kukla M., Śnietura M., Lewin-Kowalik J., Neutralization of interleukin-1 β reduces vasospasm and alters cerebral blood vessel density following experimental subarachnoid hemorrhage in rats. Current Neurovascular Research 2009 6 2 95 103 2-s2.0-65749100969 10.2174/156720209788185669
68. Hanafy K. A., Stuart R. M., Khandji A. G., Connolly E. S., Badjatia N., Mayer S. A., Schindler C., Relationship between brain interstitial fluid tumor necrosis factor- α and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Journal of Clinical Neuroscience 2010 17 7 853 856 2-s2.0-77952541231 10.1016/j.jocn.2009.11.041
69. Ducruet A. F., Gigante P. R., Hickman Z. L., Zacharia B. E., Arias E. J., Grobelny B. T., Gorski J. W., Mayer S. A., Connolly E. S. Jr., Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2010 30 4 676 688 2-s2.0-77950520468 10.1038/jcbfm.2009.278
70. Lin C.-L., Kwan A.-L., Dumont A. S., Su Y.-F., Kassell N. F., Wang C.-J., Wu S.-C., Kuo C.-L., Huang C.-S., Jeng A. Y., Liu C.-S., Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303. Journal of Neurosurgery 2007 106 3 442 448 2-s2.0-33847658409 10.3171/jns.2007.106.3.442 (Pubitemid 46354298)
71. Bavbek M., Polin R., Kwan A.-L., Arthur A. S., Kassell N. F., Lee K. S., Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998 29 9 1930 1936 2-s2.0-0031658053
72. Bowman G., Bonneau R. H., Chinchilli V. M., Tracey K. J., Cockroft K. M., A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm. Neurocritical Care 2006 5 3 222 229 2-s2.0-33846961135 10.1385/NCC:5:3:222
73. Jung C. S., Lange B., Zimmermann M., Seifert V., The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage. Neuroscience Letters 2012 524 1 20 24 2-s2.0-84864612330 10.1016/j.neulet.2012.06.076
74. Clozel M., Breu V., Burri K., Cassal J.-M., Fischli W., Gray G. A., Hirth G., Loffler B.-M., Muller M., Neidhart W., Ramuz H., Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993 365 6448 759 761 2-s2.0-0027369239 10.1038/365759a0 (Pubitemid 23339883)
75. Macdonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Marr A., Roux S., Kassell N., Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). The Lancet Neurology 2011 10 7 618 625 2-s2.0-79958803259 10.1016/S1474-4422(11)70108-9
76. Seifert V., Loffler B.-M., Zimmermann M., Roux S., Stolke D., Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. Journal of Neurosurgery 1995 82 1 55 62 2-s2.0-0028888885
77. Rousseaux P., Scherpereel B., Bernard M. H., Graftieaux J. P., Guyot J. F., Fever and cerebral vasospasm in ruptured intracranial aneurysms. Surgical Neurology 1980 14 6 459 465 2-s2.0-0019158236 (Pubitemid 11210109)
78. Weir B., Disney L., Grace M., Roberts P., Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 1989 25 2 161 165 2-s2.0-0024413781 (Pubitemid 19192419)
79. Oliveira-Filho J., Ezzeddine M. A., Segal A. Z., Buonanno F. S., Chang Y., Ogilvy C. S., Rordorf G., Schwamm L. H., Koroshetz W. J., McDonald C. T., Fever in subarachnoid hemorrhage relationship to vasospasm and outcome. Neurology 2001 56 10 1299 1304 2-s2.0-0035933109 (Pubitemid 32455287)
80. Maiuri F., Gallicchio B., Donati P., Carandente M., The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. Journal of Neurosurgical Sciences 1987 31 2 45 48 2-s2.0-0023324257
81. McGirt M. J., Mavropoulos J. C., McGirt L. Y., Alexander M. J., Friedman A. H., Laskowitz D. T., Lynch J. R., Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2003 98 6 1222 1226 2-s2.0-0037850709 (Pubitemid 36617925)
82. Neil Dwyer G., Cruickshank J., The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain 1974 97 1 79 86 2-s2.0-0016192093
83. Niikawa S., Hara S., Ohe N., Miwa Y., Ohkuma A., Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients. Neurologia Medico-Chirurgica 1997 37 12 881 885 2-s2.0-0031437299 (Pubitemid 28044689)
84. Spallone A., Acqui M., Pastore F. S., Guidetti B., Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surgical Neurology 1987 27 3 253 258 2-s2.0-0023138063 (Pubitemid 17030015)
85. Pellettieri L., Nilsson B., Carlsson C.-A., Nilsson U., Serum immunocomplexes in patients with subarachnoid hemorrhage. Neurosurgery 1986 19 5 767 771 2-s2.0-0022966725 (Pubitemid 17182145)
86. Walton J. N., The prognosis and management of subarachnoid haemorrhage. Canadian Medical Association Journal 1955 72 3 165 175 2-s2.0-0000690398
87. Mori T., Nagata K., Ishida T., Nikaido H., Kobayashi E., Sasaki T., Ohami H., Kirino T., Sequential morphological changes of the constrictive basilar artery in a canine model of experimental cerebral vasospasm by talc injection. The Journal of Veterinary Medical Science 1994 56 3 535 540 2-s2.0-0028453207
88. Nagata K., Sasaki T., Mori T., Nikaido H., Kobayashi E., Kim P., Kirino T., Cisternal talc injection in dog can induce delayed and prolonged arterial constriction resembling cerebral vasospasm morphologically and pharmacologically. Surgical Neurology 1996 45 5 442 447 2-s2.0-0029880703 10.1016/0090-3019(95)00455-6 (Pubitemid 26132002)
89. Peterson J. W., Kwun B.-D., Hackett J. D., Zervas N. T., The role of inflammation in experimental cerebral vasospasm. Journal of Neurosurgery 1990 72 5 767 774 2-s2.0-0025238859 (Pubitemid 20146421)
90. Yanamoto H., Kikuchi H., Okamoto S., Nozaki K., Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor. Surgical Neurology 1994 42 5 374 381 2-s2.0-0028052163 10.1016/0090-3019(94)90339-5 (Pubitemid 24356429)
91. Recinos P. F., Pradilla G., Thai Q.-A., Perez M., Hdeib A. M., Tamargo R. J., Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood. Surgical Neurology 2006 66 5 463 469 2-s2.0-33750475590 10.1016/j.surneu.2006.04.010 (Pubitemid 44647390)
92. Fujimoto M., Suzuki H., Shiba M., Shimojo N., Imanaka-Yoshida K., Yoshida T., Kanamaru K., Matsushima S., Taki W., Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiology of Disease 2013 55 104 109 2-s2.0-84877630967 10.1016/j.nbd.2013.01.007
93. Schmidt S., Moser M., Sperandio M., The molecular basis of leukocyte recruitment and its deficiencies. Molecular Immunology 2013 55 1 49 58 2-s2.0-84875629527 10.1016/j.molimm.2012.11.006
94. Nissen J. J., Mantle D., Gregson B., Mendelow A. D., Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies. Journal of Neurology Neurosurgery and Psychiatry 2001 71 3 329 333 2-s2.0-0034885622 10.1136/jnnp.71.3.329 (Pubitemid 32772529)
95. Oshiro E. M., Hoffman P. A., Dietsch G. N., Watts M. C., Pardoll D. M., Tamargo R. J., Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 1997 28 10 2031 2038 2-s2.0-0030705206 (Pubitemid 27459015)
96. Ni W., Gu Y. X., Song D. L., Leng B., Li P. L., Mao Y., The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. Acta Neurochirurgica, Supplementum 2011 110, part 1 203 208 2-s2.0-79952278125 10.1007/978-3-7091-0353-1-35
97. Hendryk S., Jarzab B., Josko J., Increase of the IL-1 β and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinology Letters 2004 25 1-2 141 147 2-s2.0-3242781843 (Pubitemid 44783371)
98. Nam D.-H., Kim J.-S., Hong S.-C., Lee W. H., Lee J.-I., Shin H.-J., Park K., Eoh W., Han D. H., Kim J. H., Expression of interleukin-1 β in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neuroscience Letters 2001 312 1 41 44 2-s2.0-0035851007 10.1016/S0304-3940(01)02194-2 (Pubitemid 32907548)
99. Wang Y., Zhong M., Tan X.-X., Yang Y.-J., Chen W.-J., Liu W., Zheng K., Expression change of interleukin-8 gene in rabbit basilar artery after subarachnoid hemorrhage. Neuroscience Bulletin 2007 23 3 151 155 2-s2.0-34547115928 10.1007/s12264-007-0022-1 (Pubitemid 47104869)
100. Muroi C., Seule M., Sikorski C., Dent W., Keller E., Systemic interleukin-6 levels reflect illness course and prognosis of patients with spontaneous nonaneurysmal subarachnoid hemorrhage. Acta Neurochirurgica, Supplementum 2013 115 77 80 2-s2.0-84866990764 10.1007/978-3-7091-1192-5-17
101. Lu H., Shi J.-X., Chen H.-L., Hang C.-H., Wang H.-D., Yin H.-X., Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage. Brain Research 2009 1262 73 80 2-s2.0-62049084483 10.1016/j.brainres.2009.01.017
102. Bowman G., Dixit S., Bonneau R. H., Chinchilli V. M., Cockroft K. M., Findlay J. M., Schackert G., Macdonald R. L., Connolly E. S. Jr., Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model. Neurosurgery 2004 54 3 719 726 2-s2.0-1542346492 (Pubitemid 38298747)
103. Vecchione C., Frati A., di Pardo A., Cifelli G., Carnevale D., Gentile M. T., Carangi R., Landolfi A., Carullo P., Bettarini U., Antenucci G., Mascio G., Busceti C. L., Notte A., Maffei A., Cantore G. P., Lembo G., Tumor necrosis factor- α mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 2009 54 1 150 156 2-s2.0-67649840915 10.1161/HYPERTENSIONAHA.108.128124
104. Arthur J. S. C., Ley S. C., Mitogen-activated protein kinases in innate immunity. Nature Reviews Immunology 2013 13 9 679 692 2-s2.0-84883199752 10.1038/nri3495
105. Yatsushige H., Yamaguchi M., Zhou C., Calvert J. W., Zhang J. H., Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2005 36 7 1538 1543 2-s2.0-22044455107 10.1161/01.STR. 0000170713.22011.c8 (Pubitemid 40967526)
106. Yatsushige H., Yamaguchi-Okada M., Zhou C., Calvert J. W., Cahill J., Colohan A. R. T., Zhang J. H., Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis. Acta Neurochirurgica, Supplementum 2008 104 27 31 2-s2.0-44449166721 10.1007/978-3-211-75718-5-6
107. Cuzzocrea S., Shock, inflammation and PARP. Pharmacological Research 2005 52 1 72 82 2-s2.0-19444363980 10.1016/j.phrs.2005.02.016 (Pubitemid 40725601)
108. Satoh M., Date I., Nakajima M., Takahashi K., Iseda K., Tamiya T., Ohmoto T., Ninomiya Y., Asari S., Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 2001 32 1 225 231 2-s2.0-0035148308 (Pubitemid 32063850)
109. German J. W., Gross C. E., Giclas P., Watral W., Bednar M. M., Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 1996 39 1 141 146 2-s2.0-0030002139 10.1097/00006123-199607000-00028 (Pubitemid 26230468)
110. Yanamoto H., Kikuchi H., Okamoto S., Nozaki K., Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits. Neurosurgery 1992 30 3 351 357 2-s2.0-0026690705
111. Kaminogo M., Yonekura M., Onizuka M., Yasunaga A., Shibata S., Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage. Neurologia Medico-Chirurgica 1998 38 11 704 709 2-s2.0-0031797912 (Pubitemid 28551333)
112. Yanamoto H., Kikuchi H., Sato M., Shimizu Y., Yoneda S., Okamoto S., Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 1992 30 3 358 363 2-s2.0-0026631348
113. Zhang C., Lee J.-Y., Keep R. F., Pandey A., Chaudhary N., Hua Y., Xi G., Brain edema formation and complement activation in a rat model of subarachnoid hemorrhage. Acta neurochirurgica. Supplement 2013 118 157 161 2-s2.0-84881339068
114. Zanier E. R., Zangari R., Munthe-Fog L., Hein E., Zoerle T., Conte V., Orsini F., Tettamanti M., Stocchetti N., Garred P., De Simoni M. G., Ficolin-3-mediated lectin complement pathway activation in patients with subarachnoid hemorrhage. Neurology 2014 82 2 126 134
115. Hsieh H. L., Yang C. M., Role of redox signaling in neuroinflammation and neurodegenerative diseases. BioMed Research International 2013 2013 18 484613 10.1155/2013/484613
116. Gutteridge J. M. C., The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochimica et Biophysica Acta-Lipids and Lipid Metabolism 1987 917 2 219 223 2-s2.0-0023158459 (Pubitemid 17004970)
117. Møller H. J., Peterslund N. A., Graversen J. H., Moestrup S. K., Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 2002 99 1 378 380 2-s2.0-0005136199 10.1182/blood.V99.1.378 (Pubitemid 34533008)
118. Bowman B. H., Kurosky A., Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Advances in Human Genetics 1982 12 189 454 2-s2.0-17144460129
119. Borsody M., Burke A., Coplin W., Miller-Lotan R., Levy A., Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 2006 66 5 634 640 2-s2.0-33645862596 10.1212/01.wnl.0000200781.62172. 1d (Pubitemid 43739814)
120. Chaichana K. L., Levy A. P., Miller-Lotan R., Shakur S., Tamargo R. J., Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 2007 38 12 3266 3271 2-s2.0-36448932807 10.1161/STROKEAHA.107.490003 (Pubitemid 350175747)
121. Ohnishi H., Iihara K., Kaku Y., Yamauchi K., Fukuda K., Nishimura K., Nakai M., Satow T., Nakajima N., Ikegawa M., Haptoglobin phenotype predicts cerebral vasospasm and clinical deterioration after aneurysmal subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases 2013 22 4 520 526 2-s2.0-84877040136 10.1016/j.jstrokecerebrovasdis.2013.02.005
122. Kantor E., Bayir H., Ren D., Provencio J. J., Watkins L., Crago E., Horowitz M. B., Ferrell R. E., Conley Y. P., Alexander S. A., Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2014 120 2 386 390
123. Cooke J. P., Dzau V. J., Nitric oxide synthase: role in the genesis of vascular disease. Annual Review of Medicine 1997 48 489 509 2-s2.0-0031054463 10.1146/annurev.med.48.1.489 (Pubitemid 27101848)
124. van Faassen E. E., Bahrami S., Feelisch M., Hogg N., Kelm M., Kim-Shapiro D. B., Kozlov A. V., Li H., Lundberg J. O., Mason R., Nohl H., Rassaf T., Samouilov A., Slama-Schwok A., Shiva S., Vanin A. F., Weitzberg E., Zweier J., Gladwin M. T., Nitrite as regulator of hypoxic signaling in mammalian physiology. Medicinal Research Reviews 2009 29 5 683 741 2-s2.0-67650715561 10.1002/med.20151
125. Yang Y.-M., Huang A., Kaley G., Sun D., eNOS uncoupling and endothelial dysfunction in aged vessels. American Journal of Physiology-Heart and Circulatory Physiology 2009 297 5 H1829 H1836 2-s2.0-70350459448 10.1152/ajpheart.00230.2009
126. Pradilla G., Garzon-Muvdi T., Ruzevick J. J., Bender M., Edwards L., Momin E. N., Thompson R. C., Tamargo R. J., Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage. Neurosurgery 2012 70 3 747 757 2-s2.0-80052557128 10.1227/NEU.0b013e3182363c2f
127. Sabri M., Ai J., Knight B., Tariq A., Jeon H., Shang X., Marsden P. A., MacDonald R. L., Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2011 31 1 190 199 2-s2.0-78650905978 10.1038/jcbfm.2010.76
128. Sabri M., Ai J., Marsden P. A., Macdonald R. L., Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhage. PLoS ONE 2011 6 2 2-s2.0-79952030438 10.1371/journal.pone.0017062 e17062
129. Sabri M., Ai J., Lass E., D'Abbondanza J., MacDonald R. L., Genetic elimination of eNOS reduces secondary complications of experimental subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2013 33 7 1008 1014 2-s2.0-84880327090 10.1038/jcbfm.2013.49
130. Miyauchi T., Masaki T., Pathophysiology of endothelin in the cardiovascular system. Annual Review of Physiology 1999 61 391 415 2-s2.0-0033068028 10.1146/annurev.physiol.61.1.391 (Pubitemid 29143176)
131. Mascia L., Fedorko L., Stewart D. J., Mohamed F., TerBrugge K., Ranieri V. M., Wallace M. C., Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001 32 5 1185 1189 2-s2.0-0034839779 (Pubitemid 32825807)
132. Yamaura I., Tani E., Maeda Y., Minami N., Shindo H., Endothelin-1 of canine basilar artery in vasospasm. Journal of Neurosurgery 1992 76 1 99 105 2-s2.0-0026542815
133. Zuccarello M., Boccaletti R., Romano A., Rapoport R. M., Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 1998 29 9 1924 1929 2-s2.0-0031711765 (Pubitemid 28399991)
134. Matsumura Y., Ikegawa R., Suzuki Y., Takaoka M., Uchida T., Kido H., Shinyama H., Hayashi K., Watanabe M., Morimoto S., Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sciences 1991 49 11 841 848 2-s2.0-0025850708
135. Konczalla J., Mrosek J., Wanderer S., Schuss P., Güresir E., Seifert V., Vatter H., Platz J., Functional effects of levosimendan in rat basilar arteries in vitro. Current Neurovascular Research 2013 10 2 126 133 2-s2.0-84879822180 10.2174/1567202611310020005
136. Cosentino F., McMahon E. G., Carter J. S., Katusic Z. S., Effect of endothelin(A)-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. Journal of Cardiovascular Pharmacology 1993 22 supplement 8 S332 S335 2-s2.0-0027764534 (Pubitemid 24027961)
137. Yeung P. K., Shen J., Chung S. S., Chung S. K., Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage. BMC Neuroscience 2013 14 1 131
138. Findlay J. M., Weir B. K. A., Steinke D., Tanabe T., Gordon P., Grace M., Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. Journal of Neurosurgery 1988 69 5 723 735 2-s2.0-0023744041
139. Findlay J. M., Kassell N. F., Weir B. K. A., Haley E. C. Jr., Kongable G., Germanson T., Truskowski L., Alves W. M., Holness R. O., Knuckey N. W., Yonas H., Steinberg G. K., West M., Winn H. R., Ferguson G., Loftus C. M., Batjer H. H., Giannotta S. L., Selman W. R., A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995 37 1 168 178 2-s2.0-0029053612
140. Kai Y., Ito K., Watanabe M., Morioka M., Yano S., Ohmori Y., Kawano T., Hamada J.-I., Kuratsu J.-I., Development of a kit to treat subarachnoid hemorrhage by intrathecal simple urokinase infusion (ITSUKI) therapy: preliminary results in patients with World Federation of Neurological Surgery (WFNS) Grade v subarachnoid hemorrhage. World Neurosurgery 2011 75 3-4 485 490 2-s2.0-79956213746 10.1016/j.wneu.2010.07.020
141. Hamada J.-I., Kai Y., Morioka M., Yano S., Mizuno T., Hirano T., Kazekawa K., Ushio Y., Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study. Stroke 2003 34 11 2549 2554 2-s2.0-0242525542 10.1161/01.STR.0000094731.63690.FF (Pubitemid 37392737)
142. Mizuno T., Hamada J.-I., Kai Y., Todaka T., Morioka M., Ushio Y., Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs. American Journal of Neuroradiology 2003 24 4 613 618 2-s2.0-0037393826 (Pubitemid 36460727)
143. Hamada J.-I., Mizuno T., Kai Y., Morioka M., Ushio Y., Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 2000 31 9 2141 2148 2-s2.0-0033810870
144. Amin-Hanjani S., Ogilvy C. S., Barker F. G. II, Dumont A. S., Kassell N. F., Dempsey R. J., Lawton M. T., Haines S. J., Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004 54 2 326 335 2-s2.0-1142310743 (Pubitemid 38209400)
145. Yamamoto T., Esaki T., Nakao Y., Mori K., Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage. World Neurosurgery 2010 73 6 675 682 2-s2.0-77957792028 10.1016/j.wneu.2010.04.002
146. Kim J. H., Yi H. J., Ko Y., Kim Y. S., Kim D. W., Kim J. M., Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers. Neurological Sciences 2014 35 5 715 722
147. Chyatte D., Sundt T. M. Jr., Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasone. Journal of Neurosurgery 1984 60 5 923 926 2-s2.0-0021278106 (Pubitemid 14134795)
148. Chyatte D., Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989 20 8 1021 1026 2-s2.0-0024393916 (Pubitemid 19204014)
149. Chyatte D., Rusch N., Sundt T. M. Jr., Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone. Journal of Neurosurgery 1983 59 6 925 932 2-s2.0-0021053385 (Pubitemid 14205877)
150. Chyatte D., Fode N. C., Nichols D. A., Sundt T. M. Jr., Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987 21 2 157 160 2-s2.0-0023222721 (Pubitemid 17131115)
151. Hashi K., Takakura K., Sano K., Ohta T., Saito I., Okada K., Intravenous hydrocortisone in large doses for the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage-results of a multi-center controlled double-blind clinical study. Brain and Nerve 1988 40 4 373 382 2-s2.0-0023947882
152. Katayama Y., Haraoka J., Hirabayashi H., Kawamata T., Kawamoto K., Kitahara T., Kojima J., Kuroiwa T., Mori T., Moro N., Nagata I., Ogawa A., Ohno K., Seiki Y., Shiokawa Y., Teramoto A., Tominaga T., Yoshimine T., A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007 38 8 2373 2375 2-s2.0-34548202216 10.1161/STROKEAHA.106.480038 (Pubitemid 47457586)
153. Moro N., Katayama Y., Kojima J., Mori T., Kawamata T., Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke 2003 34 12 2807 2811 2-s2.0-0344304800 10.1161/01.STR.0000103744.05430.99 (Pubitemid 37517746)
154. Mori T., Katayama Y., Kawamata T., Hirayama T., Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 1999 91 6 947 952 2-s2.0-0032735075
155. Gomis P., Graftieaux J. P., Sercombe R., Hettler D., Scherpereel B., Rousseaux P., Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2010 112 3 681 688 2-s2.0-77749254703 10.3171/2009.4.JNS081377
156. Green G. A., Understanding NSAIDs: from aspirin to COX-2. Clinical Cornerstone 2001 3 5 50 59 2-s2.0-0034800418 10.1016/S1098-3597(01)90069-9 (Pubitemid 32904246)
157. White R. P., Robertson J. T., Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm. Neurosurgery 1983 12 1 40 46 2-s2.0-0020681074 (Pubitemid 13181856)
158. Pradilla G., Thai Q.-A., Legnani F. G., Clatterbuck R. E., Gailloud P., Murphy K. P., Tamargo R. J., Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. Neurosurgery 2005 57 1 S-184 S-190 2-s2.0-21744459403 10.1227/01.NEU.0000163604.52273.28 (Pubitemid 40944131)
159. Thai Q.-A., Oshiro E. M., Tamargo R. J., Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 1999 30 1 140 147 2-s2.0-0032908502 (Pubitemid 29029455)
160. Frazier J. L., Pradilla G., Wang P. P., Tamargo R. J., Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. Journal of Neurosurgery 2004 101 1 93 98 2-s2.0-3042567010 (Pubitemid 38808466)
161. Çelik Ö., Bilginer B., Korkmaz A., Gürgör P. N., Bavbek M., Özgen T., Ziyal I., Effects of intramuscular parecoxib administration on vasospasm in an experimental subarachnoid hemorrhage model. International Journal of Neuroscience 2011 121 6 316 322 2-s2.0-79958066949 10.3109/00207454.2011.556284
162. Mani B. K., Brueggemann L. I., Cribbs L. L., Byron K. L., Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery. British Journal of Pharmacology 2011 164 2 237 249 2-s2.0-80052002206 10.1111/j.1476-5381.2011.01273.x
163. Mani B. K., O'Dowd J., Kumar L., Brueggemann L. I., Ross M., Byron K. L., Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm. Journal of Cardiovascular Pharmacology 2013 61 1 51 62 2-s2.0-84872356745 10.1097/FJC.0b013e3182771708
164. Pritchard D. I., Sourcing a chemical succession for cyclosporin from parasites and human pathogens. Drug Discovery Today 2005 10 10 688 691 2-s2.0-19444363444 10.1016/S1359-6446(05)03395-7 (Pubitemid 40724550)
165. Handa Y., Hayashi M., Takeuchi H., Kobayashi H., Kawano H., Kabuto M., Effect of cyclosporine on the development of cerebral vasospasm in a primate model. Neurosurgery 1991 28 3 380 386 2-s2.0-0025982079
166. Peterson J. W., Nishizawa S., Hackett J. D., Bun T., Teramura A., Zervas N. T., Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 1990 21 1 133 137 2-s2.0-0025191287 (Pubitemid 20052543)
167. Manno E. M., Gress D. R., Ogilvy C. S., Stone C. M., Zervas N. T., The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher Grade 3 subarachnoid hemorrhages: a pilot study. Neurosurgery 1997 40 2 289 293 2-s2.0-0031021737 10.1097/00006123-199702000-00010 (Pubitemid 27045089)
168. Ryba M., Pastuszko M., Iwanska K., Bidzinski J., Dziewiecki C., Cyclosporine A prevents neurological deterioration of patients with SAH-a preliminary report. Acta Neurochirurgica 1991 112 1-2 25 27 2-s2.0-0025949310
169. Ryba M., Pastuszko M., Dziewiecki C., Andrychowski J., Bojarski P., Barczewska M., A strategy for analyzing multiple parameters with application to aneurysmal SAH patients all of them clipped but treated with and without cyclosporine. Acta Neurochirurgica 1993 122 3-4 194 199 2-s2.0-0027172052 (Pubitemid 23219663)
170. Ryba M., Grieb P., Bidzinski J., Pastuszko M., Dziewiecki C., Iwanska K., Cyclosporine A for the prevention of neurological deficit following subarachnoid hemorrhage. Stroke 1991 22 4 531 2-s2.0-0025808867
171. Mori T., Nagata K., Ishida T., Sasaki T., Nirei H., Hamada K., Ohami H., Kirino T., FK-506: a new immunosuppressive agent, failed to reduce cerebral vasospasm after experimental subarachnoid hemorrhage. The Journal of Veterinary Medical Science 1993 55 4 581 586 2-s2.0-0027645960
172. Nagata K., Sasaki T., Iwama J., Mori T., Iwamoto S., Nirei H., Hamada K., Kirino T., Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model. Journal of Neurosurgery 1993 79 5 710 715 2-s2.0-0027382025 (Pubitemid 23320889)
173. Nishizawa S., Peterson J. W., Shimoyama I., Iwasaki K., Uemura K., Weir B. K., Chyatte D., Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. Neurosurgery 1993 32 6 986 992 2-s2.0-0027173088 (Pubitemid 23157381)
174. Ascer E., Bertolami M. C., Venturinelli M. L., Buccheri V., Souza J., Nicolau J. C., Ramires J. A. F., Serrano C. V. Jr., Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 2004 177 1 161 166 2-s2.0-5444260617 10.1016/j.atherosclerosis.2004.07.003 (Pubitemid 39361151)
175. Chello M., Carassiti M., Agrò F., Mastroroberto P., Pugliese G., Colonna D., Covino E., Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 2004 18 5 605 609 2-s2.0-5644250618 10.1053/j.jvca.2004.07.019 (Pubitemid 39369959)
176. Chang C.-Z., Wu S.-C., Lin C.-L., Hwang S.-L., Howng S.-L., Kwan A.-L., Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats. Acta Neurochirurgica 2010 152 8 1399 1405 2-s2.0-77956190763 10.1007/s00701-010-0652-3
177. McGirt M. J., Lynch J. R., Parra A., Sheng H., Pearlstein R. D., Laskowitz D. T., Pelligrino D. A., Warner D. S., Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002 33 12 2950 2956 2-s2.0-0036901538 10.1161/01.STR.0000038986.68044.39 (Pubitemid 35462871)
178. Doo Y.-C., Han S.-J., Han S.-W., Park W.-J., Choi S.-H., Cho G.-Y., Hong K.-S., Han K.-R., Lee N.-H., Oh D.-J., Ryu K.-H., Rim C.-Y., Lee K.-H., Lee Y., Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting. Clinical Cardiology 2005 28 2 72 76 2-s2.0-20844460951 (Pubitemid 40209379)
179. Koh K. K., Son J. W., Ahn J. Y., Jin D. K., Kim H. S., Choi Y. M., Ahn T. H., Kim D. S., Shin E. K., Vascular effects of diet and statin in hypercholesterolemic patients. International Journal of Cardiology 2004 95 2-3 185 191 2-s2.0-2942606249 10.1016/j.ijcard.2003.05.018 (Pubitemid 38757625)
180. Rezaie-Majd A., Prager G. W., Bucek R. A., Schernthaner G. H., Maca T., Kress H.-G., Valent P., Binder B. R., Minar E., Baghestanian M., Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 3 397 403 2-s2.0-0037339680 10.1161/01.ATV.0000059384.34874.F0 (Pubitemid 36337214)
181. Parra A., Kreiter K. T., Williams S., Sciacca R., Mack W. J., Naidech A. M., Commichau C. S., Fitzsimmons B.-F. M., Janjua N., Mayer S. A., Connolly E. S. Jr., Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 2005 56 3 476 484 2-s2.0-20044362739 10.1227/01.NEU. 0000153925.96889.8A (Pubitemid 40316367)
182. Kramer A. H., Gurka M. J., Nathan B., Dumont A. S., Kassell N. F., Bleck T. P., Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 2008 62 2 422 427 2-s2.0-41749089775 10.1227/01.neu.0000316009.19012.e3
183. McGirt M. J., Garces Ambrossi G. L., Huang J., Tamargo R. J., Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study: clinical article. Journal of Neurosurgery 2009 110 5 968 974 2-s2.0-66849109427 10.3171/2008.10.JNS08901
184. Sanchez-Peña P., Nouet A., Clarençon F., Colonne C., Jean B., Le Jean L., Fonfrede M., Aout M., Vicaut E., Puybasset L., Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study. Critical Care Medicine 2012 40 2 594 602 2-s2.0-84856145965 10.1097/CCM.0b013e31822f05e7
185. Tseng M.-Y., Czosnyka M., Richards H., Pickard J. D., Kirkpatrick P. J., Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005 36 8 1627 1632 2-s2.0-23244432198 10.1161/01.STR.0000176743.67564.5d (Pubitemid 41098752)
186. Tseng M.-Y., Hutchinson P. J., Czosnyka M., Richards H., Pickard J. D., Kirkpatrick P. J., Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007 38 5 1545 1550 2-s2.0-34247622293 10.1161/STROKEAHA.106.475905 (Pubitemid 46684172)
187. Liu Z., Liu L., Zhang Z., Chen Z., Zhao B., Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage. The Cochrane Database of Systematic Reviews 2013 4 CD008184
188. Pluta R. M., Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacology and Therapeutics 2005 105 1 23 56 2-s2.0-11044230424 10.1016/j.pharmthera.2004.10.002 (Pubitemid 40044766)
189. Pluta R. M., Dejam A., Grimes G., Gladwin M. T., Oldfield E. H., Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of the American Medical Association 2005 293 12 1477 1484 2-s2.0-15044344420 10.1001/jama.293.12.1477 (Pubitemid 40393292)
190. Gabikian P., Clatterbuck R. E., Eberhart C. G., Tyler B. M., Tierney T. S., Tamargo R. J., Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke 2002 33 11 2681 2686 2-s2.0-0036842246 10.1161/01.STR.0000033931.62992.B1 (Pubitemid 35266441)
191. Pradilla G., Thai Q.-A., Legnani F. G., Hsu W., Kretzer R. M., Wang P. P., Tamargo R. J., Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 2004 55 6 1393 1400 2-s2.0-10044289649 10.1227/01.NEU.0000143615. 26102.1A (Pubitemid 39612889)
192. Pluta R. M., Oldfield E. H., Boock R. J., Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery 1997 87 5 746 751 2-s2.0-0030668002 (Pubitemid 27454594)
193. Egemen N., Turker R. K., Sanlidilek U., Zorlutuna A., Bilgic S., Baskaya M., Unlu A., Caglar S., Spetzler R. F., McCormick J. M., The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurological Research 1993 15 5 310 315 2-s2.0-0027422844 (Pubitemid 23333733)
194. Fathi A. R., Pluta R. M., Bakhtian K. D., Qi M., Lonser R. R., Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates: laboratory investigation. Journal of Neurosurgery 2011 115 6 1213 1220 2-s2.0-83055172318 10.3171/2011.7.JNS11390
195. Solomonson L. P., Flam B. R., Pendleton L. C., Goodwin B. L., Eichler D. C., The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. The Journal of Experimental Biology 2003 206 12 2083 2087 2-s2.0-0038269336 10.1242/jeb.00361 (Pubitemid 36761811)
196. Kubes P., Suzuki M., Granger D. N., Nitric oxide: an endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Sciences of the United States of America 1991 88 11 4651 4655 2-s2.0-0025731835 (Pubitemid 21914599)
197. Suematsu M., Tamatani T., Delano F. A., Miyasaka M., Forrest M., Suzuki H., Schmid-Schonbein G. W., Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression. American Journal of Physiology-Heart and Circulatory Physiology 1994 266 6 H2410 H2415 2-s2.0-0028001936
198. Kurose I., Kubes P., Wolf R., Anderson D. C., Paulson J., Miyasaka M., Granger D. N., Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circulation Research 1993 73 1 164 171 2-s2.0-0027247634 (Pubitemid 23173067)
199. Kubes P., Granger D. N., Nitric oxide modulates microvascular permeability. American Journal of Physiology-Heart and Circulatory Physiology 1992 262 2 H611 H615 2-s2.0-0026507703
200. Gaboury J., Woodman R. C., Granger D. N., Reinhardt P., Kubes P., Nitric oxide prevents leukocyte adherence: role of superoxide. American Journal of Physiology-Heart and Circulatory Physiology 1993 265 3, part 2 H862 H867 2-s2.0-0027435577 (Pubitemid 23296588)
201. Macdonald R. L., Delayed neurological deterioration after subarachnoid haemorrhage. Nature Reviews: Neurology 2014 10 1 44 58
202. Chen G., Tariq A., Ai J., Sabri M., Jeon H.-J., Tang E. J. Y., Lakovic K., Wan H., Macdonald R. L., Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats. Brain Research 2011 1392 132 139 2-s2.0-79955935925 10.1016/j.brainres.2011.03.068
203. MacDonald R. L., Kassell N. F., Mayer S., Ruefenacht D., Schmiedek P., Weidauer S., Frey A., Roux S., Pasqualin A., Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008 39 11 3015 3021 2-s2.0-55749089548 10.1161/STROKEAHA.108. 519942
204. Vergouwen M. D. I., Algra A., Rinkel G. J. E., Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2012 43 10 2671 2676 2-s2.0-84866736325 10.1161/STROKEAHA.112.666693
205. Kambayashi J., Liu Y., Sun B., Shakur Y., Yoshitake M., Czerwiec F., Cilostazol as a unique antithrombotic agent. Current Pharmaceutical Design 2003 9 28 2289 2302 2-s2.0-0141885183 10.2174/1381612033453910 (Pubitemid 37236353)
206. Jung W.-K., Lee D.-Y., Park C., Choi Y. H., Choi I., Park S.-G., Seo S.-K., Lee S.-W., Yea S. S., Ahn S.-C., Lee C.-M., Park W. S., Ko J.-H., Choi I.-W., Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases. British Journal of Pharmacology 2010 159 6 1274 1285 2-s2.0-77949388928 10.1111/j.1476-5381.2009.00615.x
207. Ito H., Fukunaga M., Suzuki H., Miyakoda G., Ishikawa M., Yabuuchi Y., Taki W., Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging. Neurobiology of Disease 2008 32 1 157 161 2-s2.0-51349092362 10.1016/j.nbd.2008.07.004
208. Yamaguchi-Okada M., Nishizawa S., Mizutani A., Namba H., Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Cerebrovascular Diseases 2009 28 2 135 142 2-s2.0-66449094090 10.1159/000223439
209. Yoshimoto T., Shirasaka T., Fujimoto S., Yoshidumi T., Yamauchi T., Tokuda K., Kaneko S., Kashiwaba T., Cilostazol may prevent cerebral vasospasm following subarachnoid hemorrhage. Neurologia Medico-Chirurgica 2009 49 6 235 241 2-s2.0-67650911927 10.2176/nmc.49.235
210. Murahashi T., Kamiyama K., Hara K., Ozaki M., Mikamoto M., Nakagaki Y., Nakagaki Y., Nakamura H., The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage. Neurological Surgery 2013 41 5 393 400 2-s2.0-84878409687
211. Senbokuya N., Kinouchi H., Kanemaru K., Ohashi Y., Fukamachi A., Yagi S., Shimizu T., Furuya K., Uchida M., Takeuchi N., Nakano S., Koizumi H., Kobayashi C., Fukasawa I., Takahashi T., Kuroda K., Nishiyama Y., Yoshioka H., Horikoshi T., Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial-clinical article. Journal of Neurosurgery 2013 118 1 121 130 2-s2.0-84872197756 10.3171/2012.9.JNS12492
212. Shechter R., Schwartz M., Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer if' but how'. Journal of Pathology 2013 229 2 332 346 2-s2.0-84871060866 10.1002/path.4106
213. Gidday J. M., Gasche Y. G., Copin J.-C., Shah A. R., Perez R. S., Shapiro S. D., Chan P. H., Park T. S., Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. American Journal of Physiology-Heart and Circulatory Physiology 2005 289 2 H558 H568 2-s2.0-23744437416 10.1152/ajpheart.01275.2004 (Pubitemid 41129369)
214. Yepes M., Winkles J. A., Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases. Drug News and Perspectives 2006 19 10 589 595 2-s2.0-34247630755 10.1358/dnp.2006.19.10.1068005 (Pubitemid 46813845)
215. Zhang X., Winkles J. A., Gongora M. C., Polavarapu R., Michaelson J. S., Hahm K., Burkly L., Friedman M., Li X.-J., Yepes M., TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2007 27 3 534 544 2-s2.0-33847209525 10.1038/sj.jcbfm.9600368
216. Katan M., Elkind M. S., Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Expert Review of Neurotherapeutics 2011 11 2 225 239 2-s2.0-79951604546 10.1586/ern.10.200
217. Ostrowski R. P., Colohan A. R., Zhang J. H., Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurological Research 2006 28 4 399 414 2-s2.0-33745652438 10.1179/016164106X115008 (Pubitemid 43967787)
218. Macdonald R. L., Delayed neurological deterioration after subarachnoid haemorrhage. Nature Reviews Neurology 2014 10 1 44 58
219. Caner B., Hou J., Altay O., Fuj M. II, Zhang J. H., Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. Journal of Neurochemistry 2012 123 supplement 2 12 21 2-s2.0-84867541527 10.1111/j.1471-4159.2012.07939.x
220. Dorhout Mees S. M., Rinkel G. J., Feigin V. L., Algra A., van den Bergh W. M., Vermeulen M., van Gijn J., Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2007 3 CD000277 2-s2.0-35348846464
221. Feigin V. L., Rinkel G. J. E., Algra A., Vermeulen M., van Gijn J., Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998 50 4 876 883 2-s2.0-0031922760 (Pubitemid 28212809)
222. Macdonald R. L., Delayed neurological deterioration after subarachnoid haemorrhage. Nature Reviews Neurology 2014 10 1 44 58
223. Vergouwen M. D. I., Vermeulen M., van Gijn J., Rinkel G. J. E., Wijdicks E. F., Muizelaar J. P., Mendelow A. D., Juvela S., Yonas H., Terbrugge K. G., Macdonald R. L., Diringer M. N., Broderick J. P., Dreier J. P., Roos Y. B. W. E. M., Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010 41 10 2391 2395 2-s2.0-77958142127 10.1161/STROKEAHA.110.589275
224. Feigin V. L., Anderson N., Rinkel G. J., Algra A., van Gijn J., Bennett D. A., Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database of Systematic Reviews 2005 3 CD004583 2-s2.0-32944480950
225. Yatsushige H., Ostrowski R. P., Tsubokawa T., Colohan A., Zhang J. H., Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. Journal of Neuroscience Research 2007 85 7 1436 1448 2-s2.0-34248155678 10.1002/jnr.21281 (Pubitemid 46724387)
226. Bendel P., Koivisto T., Hänninen T., Kolehmainen A., Könönen M., Hurskainen H., Pennanen C., Vanninen R., Subarachnoid hemorrhage is followed by temporomesial volume loss: MRI volumetric study. Neurology 2006 67 4 575 582 2-s2.0-33747637130 10.1212/01.wnl.0000230221.95670. bf (Pubitemid 44273601)
227. Petzold A., Keir G., Kay A., Kerr M., Thompson E. J., Axonal damage and outcome in subarachnoid haemorrhage. Journal of Neurology, Neurosurgery and Psychiatry 2006 77 6 753 759 2-s2.0-33646834717 10.1136/jnnp.2005.085175 (Pubitemid 43837203)
228. Lad S. P., Hegen H., Gupta G., Deisenhammer F., Steinberg G. K., Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases 2012 21 1 30 41 2-s2.0-84855506803 10.1016/j.jstrokecerebrovasdis.2010. 04.004
229. Ruigrok Y. M., Slooter A. J. C., Bardoel A., Frijns C. J. M., Rinkel G. J. E., Wijmenga C., Genes and outcome after aneurysmal subarachnoid haemorrhage. Journal of Neurology 2005 252 4 417 422 2-s2.0-17744374672 10.1007/s00415-005- 0661-y (Pubitemid 40576904)
230. Donnelly D. J., Popovich P. G., Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Experimental Neurology 2008 209 2 378 388 2-s2.0-38749086493 10.1016/j.expneurol.2007.06.009 (Pubitemid 351181428)
231. Hoh B. L., Hosaka K., Downes D. P., Nowicki K. W., Fernandez C. E., Batich C. D., Scott E. W., Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1 α and macrophage inflammatory protein-2-dependent pathway. Circulation 2011 124 20 2243 2252 2-s2.0-81355148549 10.1161/CIRCULATIONAHA.111. 036061
232. Steer K. A., Wallace T. M., Bolton C. H., Hartog M., Aspirin protects low density lipoprotein from oxidative modification. Heart 1997 77 4 333 337 2-s2.0-0030916999 (Pubitemid 27208173)
233. Ferri N., Corsini A., Clinical evidence of statin therapy in non-dyslipidemic disorders. Pharmacological Research 2014 10.1016/j.phrs.2014. 02.003
234. Smithason S., Moore S. K., Provencio J. J., Low-dose lipopolysaccharide injection prior to subarachnoid hemorrhage modulates delayed deterioration associated with vasospasm in subarachnoid hemorrhage. Acta Neurochirurgica, Supplementum 2013 115 253 258 2-s2.0-84867006566 10.1007/978-3-7091-1192-5-45
235. Kim Y. W., Zipfel G. J., Ogilvy C. S., Pricola K. L., Welch B. G., Shakir N., Patel B., Reavey-Cantwell J. F., Kelman C. R., Albuquerque F. C., Kalani M. Y., Hoh B. L., Preconditioning effect on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2014 74 4 351 359
236. Konstantinov I. E., Arab S., Kharbanda R. K., Li J., Cheung M. M. H., Cherepanov V., Downey G. P., Liu P. P., Cukerman E., Coles J. G., Redington A. N., The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiological Genomics 2005 19 143 150 2-s2.0-19944391882 10.1152/physiolgenomics.00046.2004 (Pubitemid 40039920)